PMID: 376416May 24, 1979Paper

Utilization of a synthetic skin substitute instead of split skin in cross-leg-flap and other pedicle flap grafting

Fortschritte der Medizin
H H Spitalny, G Lemperle

Abstract

The method using synthetic skin substitute Epigard as a long-term coverage for donor sites in cross-leg-flap- and other plastic surgery procedures is described. The double-layered polyurethane/Teflon-material can be left on the wound for several weeks to avoid bacterial contamination during holding periods and to prepare regrafting of skin flaps. Experiences based on 32 cases are described.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.